Second Opinion: Pediatric COVID-19 Vaccines

The mRNA vaccines by Pfizer BioNTech and Moderna have been approved by the Centers for Disease Control for children as young as 6 months. Today, Contemporary Pediatrics talks with Carlton KK Lee, editor for The Clinical Pharmacologist’s Notebook for Contemporary Pediatrics; Residency Program Director, and associate professor, Department of Pediatrics, John Hopkins Medical Institutions, Baltimore Maryland; and Andrew J. Schuman, clinical assistant professor of pediatrics, Geisel School of Medicine at Dartmouth, Hanover New Hampshire as to who is best equipped to deliver the COVID vaccines to our littlest population.